Cas no 4033-42-5 (N-Acetyl-L-leucylglycine)
N-Acetyl-L-leucylglycine Chemical and Physical Properties
Names and Identifiers
-
- Glycine,N-acetyl-L-leucyl-
- AC-LEU-GLY-OH
- ACETYL-L-LEUCYL GLYCINE
- N-acetyl-L-leucylglycine
- 4033-42-5
- EN300-23389840
- 2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]acetic acid
- CHEMBL52988
- SCHEMBL468739
- (S)-2-(2-acetamido-4-methylpentanamido)acetic acid
- 2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid
- N-Acetyl-L-leucylglycine
-
- MDL: MFCD00037775
- Inchi: 1S/C10H18N2O4/c1-6(2)4-8(12-7(3)13)10(16)11-5-9(14)15/h6,8H,4-5H2,1-3H3,(H,11,16)(H,12,13)(H,14,15)/t8-/m0/s1
- InChI Key: QWUFVYSSHGGOCQ-QMMMGPOBSA-N
- SMILES: O=C([C@H](CC(C)C)NC(C)=O)NCC(=O)O
Computed Properties
- Exact Mass: 230.12700
- Monoisotopic Mass: 230.12665706g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 16
- Rotatable Bond Count: 8
- Complexity: 276
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.1
- Topological Polar Surface Area: 95.5?2
Experimental Properties
- PSA: 95.50000
- LogP: 0.51980
N-Acetyl-L-leucylglycine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | A305348-10mg |
N-Acetyl-L-leucylglycine |
4033-42-5 | 10mg |
$ 50.00 | 2022-06-08 | ||
| TRC | A305348-50mg |
N-Acetyl-L-leucylglycine |
4033-42-5 | 50mg |
$ 95.00 | 2022-06-08 | ||
| TRC | A305348-100mg |
N-Acetyl-L-leucylglycine |
4033-42-5 | 100mg |
$ 135.00 | 2022-06-08 | ||
| Enamine | EN300-23389840-0.05g |
2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid |
4033-42-5 | 95% | 0.05g |
$407.0 | 2024-06-19 | |
| Enamine | EN300-23389840-0.1g |
2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid |
4033-42-5 | 95% | 0.1g |
$427.0 | 2024-06-19 | |
| Enamine | EN300-23389840-0.25g |
2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid |
4033-42-5 | 95% | 0.25g |
$447.0 | 2024-06-19 | |
| Enamine | EN300-23389840-0.5g |
2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid |
4033-42-5 | 95% | 0.5g |
$465.0 | 2024-06-19 | |
| Enamine | EN300-23389840-1.0g |
2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid |
4033-42-5 | 95% | 1.0g |
$485.0 | 2024-06-19 | |
| Enamine | EN300-23389840-2.5g |
2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid |
4033-42-5 | 95% | 2.5g |
$949.0 | 2024-06-19 | |
| Enamine | EN300-23389840-5.0g |
2-[(2S)-2-acetamido-4-methylpentanamido]acetic acid |
4033-42-5 | 95% | 5.0g |
$1406.0 | 2024-06-19 |
N-Acetyl-L-leucylglycine Related Literature
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
Additional information on N-Acetyl-L-leucylglycine
Introduction to N-Acetyl-L-leucylglycine (CAS No 4033-42-5)
N-Acetyl-L-leucylglycine, a compound with the chemical identifier CAS No 4033-42-5, is a synthetic peptide that has garnered significant attention in the field of pharmaceutical and biochemical research. This peptide, characterized by its specific amino acid sequence, has been studied for its potential applications in various therapeutic areas, including drug delivery systems, protease inhibition, and as a precursor in the synthesis of more complex biomolecules.
The structure of N-Acetyl-L-leucylglycine consists of an acetylated N-terminal leucine residue followed by a glycine residue. This unique arrangement contributes to its distinct chemical properties and biological activities. The acetylation at the N-terminus enhances the stability and solubility of the peptide, making it more suitable for use in aqueous environments such as biological fluids. Additionally, the presence of leucine and glycine in its sequence imparts specific interactions with biological targets, which can be exploited for therapeutic purposes.
In recent years, N-Acetyl-L-leucylglycine has been explored for its role in drug development and delivery. Its ability to form stable complexes with other molecules has made it a promising candidate for enhancing the bioavailability and targeted delivery of drugs. For instance, studies have shown that when combined with certain therapeutic agents, N-Acetyl-L-leucylglycine can improve the pharmacokinetic properties of these drugs, leading to more efficient treatment outcomes.
Moreover, N-Acetyl-L-leucylglycine has been investigated for its potential in protease inhibition. Proteases are enzymes that play crucial roles in various physiological processes, including inflammation and cancer progression. By inhibiting specific proteases, N-Acetyl-L-leucylglycine has shown promise in modulating these processes and could potentially be developed into therapeutic agents for conditions such as rheumatoid arthritis and certain types of cancer.
Recent research has also highlighted the use of N-Acetyl-L-leucylglycine as a building block for more complex peptides and proteins. Its simple yet versatile structure allows for modifications at both ends of the molecule, enabling scientists to design custom peptides with specific functionalities. This has opened up new avenues in synthetic biology and biotechnology, where N-Acetyl-L-leucylglycine can be used to create novel biomaterials with applications ranging from tissue engineering to biosensing.
The synthesis of N-Acetyl-L-leucylglycine typically involves solid-phase peptide synthesis (SPPS), a widely used method for producing peptides of defined sequences. This approach allows for high yields and purity, making it suitable for both research and industrial applications. The growing interest in this peptide underscores its importance as a valuable tool in modern chemistry and biology.
As our understanding of biological systems continues to evolve, the applications of N-Acetyl-L-leucylglycine are likely to expand further. Ongoing studies are exploring its potential in areas such as immunomodulation and anti-viral therapies. The ability to modify its structure to enhance specific properties makes it a versatile molecule that can be tailored to meet various research and therapeutic needs.
In conclusion, N-Acetyl-L-leucylglycine (CAS No 4033-42-5) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structure and biological activities make it a valuable asset in drug design, protease inhibition, and synthetic biology. As new research emerges, we can expect to see even broader applications for this remarkable peptide in the future.
4033-42-5 (N-Acetyl-L-leucylglycine) Related Products
- 3303-34-2(L-Alanyl-L-leucine)
- 1999-42-4(DL-Alanyl-DL-leucine)
- 13588-95-9(H-Leu-val-OH)
- 183449-57-2(L-Alanine,5-oxo-L-prolyl-L-phenylalanyl-L-arginyl-L-histidyl-L-a-aspartyl-L-serylglycyl-L-tyrosyl-L-a-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-a-glutamyl-L-a-aspartyl-L-valylglycyl-L-seryl-L-asparaginyl-L-lysylglycyl-L-alanyl-L-isoleucyl-L-isoleucylglycyl-L-leucyl-L-methionyl-L-valylglycylglycyl-L-valyl-L-valyl-L-isoleucyl-)
- 17665-02-0(L-Leucyl-D-leucine)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)